ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions

Prostate

Volumn 54, Issue 1, 2003, Pages 34-43

  Kristiansen, Glen ^a   Pilarsky, Christian ^b   Wissmann, Christoph ^b   Stephan, Carsten ^a   Weissbach, Lothar ^c   Loy, Volker ^c   Loening, Stefan ^a   Dietel, Manfred ^a   Rosenthal, André ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Metagen GmbH   (Germany)

^c VIVANTES KLINIKUM AM URBAN   (Germany)

Author keywords

ALCAM; CD166; Immunohistochemistry; Microarray hybridization; Prostate cancer

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; RNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RNA ANALYSIS; RNA HYBRIDIZATION; UPREGULATION;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; ADULT; AGED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATE; PROSTATIC NEOPLASMS; RNA; UP-REGULATION;

EID: 0037218432     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10161     Document Type: Article

References (23)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Robin H. The Oncogene and Tumour Suppressor Gene Facts Book. San Diego: Academic Press, Harcourt Brace & Company; 1997.
3. Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U, Haynes BF, Aruffo A. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 1995;181:2213-2220.
4. Pourquie O, Corbel C, Le Caer JP, Rossier J, Le Douarin NM. BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc Natl Acad Sci USA 1992;89:5261-5265.
5. Tanaka H, Matsui T, Agata A, Tomura M, Kubota I, McFarland KC, Kohr B, Lee A, Phillips HS, Shelton DL. Molecular cloning and expression of a novel adhesion molecule, SC1. Neuron 1991;7:535-545.
6. Burns FR, von Kannen S, Guy L, Raper JA, Kamholz J, Chang S. DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron 1991;7:209-220.
7. Bowen MA, Aruffo A. Adhesion molecules, their receptors, and their regulation: Analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions. Transplant Proc 1999;31:795-796.
8. Patel DD, Wee SF, Whichard LP, Bowen MA, Pesando JM, Aruffo A, Haynes BF. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells. J Exp Med 1995;181:1563-1568.
9. DeBernardo AP, Chang S. Heterophilic interactions of DM- GRASP: GRASP-NgCAM interactions involved in neurite extension. J Cell Biol 1996;133:657-666.
10. Matsumoto A, Mitchell A, Kurata H, Pyle L, Kondo K, Itakura H, Fidge N. Cloning and characterization of HB2, a candidate high density lipoprotein receptor. Sequence homology with members of the immunoglobulin superfamily of membrane proteins. J Biol Chem 1997;272:16778-16782.
11. Degen WG, van Kempen LC, Gijzen EG, van Groningen JJ, van Kooyk Y, Bloemers HP, Swart GW. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Am J Pathol 1998;152:805-813.
12. van Kempen LC, van den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, Swart GW. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol 2000;156:769-774.
13. Tomita K, van Bokhoven A, Jansen CF, Bussemakers MJ, Schalken JA. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin. Biochem Biophys Res Commun 2000;267:870-874.
14. Stamey TA, Warrington JA, Caldwell MC, Chen Z, Fan Z, Mahadevappa M, McNeal JE, Nolley R, Zhang Z. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 2001;166:2171-2177.
15. Schmitt AO, Specht T, Beckmann G, Dahl E, Pilarsky CP, Hinzmann B, Rosenthal A. Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues. Nucleic Acids Res 1999;27:4251-4260.
16. Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR, Erlander MG. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 1999;5:117-122.
17. Ohneda O, Ohneda K, Arai F, Lee J, Miyamoto T, Fukushima Y, Dowbenko D, Lasky LA, Suda T. ALCAM (CD166): Its role in hematopoietic and endothelial development. Blood 2001;98:2134-2142.
18. van Kempen LC, Nelissen JM, Degen WG, Torensma R, Weidle UH, Bloemers HP, Figdor CG, Swart GW. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 2001;276:25783-25790.
19. Choi S, Kobayashi M, Wang J, Habelhah H, Okada F, Hamada J, Moriuchi T, Totsuka Y, Hosokawa M. Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin. Clin Exp Metastasis 2000;18:45-50.
20. Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM, Isaacs WB. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Res 2001;61:4683-4688.
21. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF Jr, Hampton GM. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-5978.
22. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM. Delineation of prognostic biomarkers in prostate cancer. Nature 2001;412:822-826.
23. Bouras T, Frauman AG. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: A biphasic relationship with tumour grade. J Pathol 1999;188:382- 388.